![Jana Machan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jana Machan
Direttore operativo presso Centre For Commercialization of Regenerative Medicine
Provenienza dei contatti di primo grado di Jana Machan
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Centre For Commercialization of Regenerative Medicine
![]() Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.
15
| Non-Profit Organization | Biotechnology | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jana Machan tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Toronto | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal | |
Saisei Ventures LLC
![]() Saisei Ventures LLC Investment ManagersFinance Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Founder | |
ExCellThera, Inc.
![]() ExCellThera, Inc. BiotechnologyHealth Technology ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013. | Biotechnology | Chairman Founder | |
Alliance for Regenerative Medicine
![]() Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Wellesley Hospital | Chief Tech/Sci/R&D Officer | ||
Royal Society of Canada
![]() Royal Society of Canada Miscellaneous Commercial ServicesCommercial Services The Royal Society of Canada offers educational courses. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Iris Almeida-Cote. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Notch Therapeutics, Inc.
![]() Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Founder | |
Michael Smith Laboratories
![]() Michael Smith Laboratories Miscellaneous Commercial ServicesCommercial Services Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Gamma Biosciences
![]() Gamma Biosciences Packaged SoftwareTechnology Services Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA. | Packaged Software | Chief Tech/Sci/R&D Officer | |
Arthritis Research Foundation | Director/Board Member | ||
Cornell University Graduate School | College/University | Doctorate Degree | |
University of Notre Dame | College/University | Undergraduate Degree | |
Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
University Health Network
![]() University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
American Institute For Medical & Biological Engineering
![]() American Institute For Medical & Biological Engineering Miscellaneous Commercial ServicesCommercial Services American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Ontario Institute for Cancer Research
![]() Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Director/Board Member | |
The Centre for the Commercialization of Antibodies & Biologics
![]() The Centre for the Commercialization of Antibodies & Biologics Pharmaceuticals: MajorHealth Technology The Centre for the Commercialization of Antibodies & Biologics is a Canadian company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member | |
Foundation For Cell & Gene Medicine | Director/Board Member | ||
Omniabio, Inc.
![]() Omniabio, Inc. BiotechnologyHealth Technology Omniabio, Inc. is a subsidiary of CCRM and is a contract development and manufacturing organization producing gene-modified cells and viral vectors, compliant with current good manufacturing practices standards. The private company's facility, located at McMaster Innovation Park in Hamilton, Canada, will be the first commercial-scale CDMO dedicated to cell and gene therapies and is expected to be the largest facility of its kind. The company is based in Hamilton, Canada and is supported by the government of Ontario via the Invest Ontario Fund. Omniabio will anchor a biomanufacturing center of excellence and will open in three phases between 2024 and 2026. The CEO of the Canadian company is Mitchel Sivilotti. | Biotechnology | Chairman | |
CCRM Enterprises Inc | Chief Executive Officer | ||
ExCellThera Ltd. | Chairman | ||
Rimon Therapeutics Ltd.
![]() Rimon Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
The Canadian Academy of Health Sciences | Corporate Officer/Principal | ||
American Association for the Advancement of Science
![]() American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
20/20 Vision Centers, Inc.
![]() 20/20 Vision Centers, Inc. Medical/Nursing ServicesHealth Services 20/20 Vision Centers, Inc. provides lasik surgery services. It offers refractive laser surgery that treats nearsightedness, farsightedness and astigmatism with incisions. It uses technology such as Nidek and Visx Star S3 Laser, Orbscan, and Hansatome Microkeratome. The company is headquartered in Murray, UT. | Medical/Nursing Services | Director/Board Member | |
Hippolyte Capital | Director/Board Member | ||
Ryne Biotechnology, Inc.
![]() Ryne Biotechnology, Inc. BiotechnologyHealth Technology Ryne Biotechnology, Inc. is an American US-based biotechnology company that focuses on developing next-generation approaches to cure neurological disorders. The company utilizes induced pluripotent stem cell (iPSC) technology to advance its off-the-shelf neuron replacement therapeutics. Ryne Bio is dedicated to advancing a pipeline targeting neurological diseases by focusing on an iPSC technology platform and forging partnerships with leaders in surgical delivery and clinical development. | Biotechnology | Founder | |
John Molson School of Business | College/University | Masters Business Admin | |
McGill University | College/University | Doctorate Degree | |
Insitut de Recherche en Immunologie et en Cancérologie
![]() Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Consultant / Advisor | |
HEALIOS K.K. | Pharmaceuticals: Major | Private Equity Investor | |
Decam AB
![]() Decam AB Advertising/Marketing ServicesCommercial Services Decam AB provides advertising services and business solutions. The private company is based in Karlskrona, Sweden and has subsidiaries in Sweden. | Advertising/Marketing Services | Comptroller/Controller/Auditor | |
Venture Cup Ost | Corporate Officer/Principal | ||
ALMI Företagspartner AB
![]() ALMI Företagspartner AB Finance/Rental/LeasingFinance ALMI Företagspartner AB provides financing and business development consulting services. Its task to be responsible for management, coordination, development of products and activities plus the servicing of group-wide functions of its subsidiaries. The company was founded in 1994 and is headquartered in Stockholm, Sweden. | Finance/Rental/Leasing | Sales & Marketing | |
Founders Loft | Director/Board Member | ||
Order of Canada
![]() Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Tourism Planet AB | Corporate Officer/Principal | ||
Connect Sverige Region Syd
![]() Connect Sverige Region Syd Investment ManagersFinance Connect Sverige Region Syd operates as a non-profit organization that offers financial advices and entrepreneurial support. The company was founded in 1999 and is headquartered in Lund, Sweden. | Investment Managers | Corporate Officer/Principal | |
Connect2capital | Corporate Officer/Principal | ||
West Swedish Incubators | Corporate Officer/Principal | ||
GU Ventures AB
![]() GU Ventures AB Investment ManagersFinance GU Ventures AB (GU Ventures) is a venture capital subsidiary of University of Gothenburg founded in 1995. The firm is headquartered in Gothenburg, Sweden. | Investment Managers | Public Communications Contact | |
Cytiva Sweden AB
![]() Cytiva Sweden AB Medical SpecialtiesHealth Technology Cytiva Sweden AB develops and manufactures products used in the production of biotechnological medicines. It is also involved in the producing, and marketing of products for the separation and analysis of biomolecules. The company is headquartered in Uppsala, Sweden. | Medical Specialties | Chairman | |
Asymptote Ltd.
![]() Asymptote Ltd. Packaged SoftwareTechnology Services Part of Cytiva CTH Holding Ltd., Asymptote Ltd. is a British company that develops cryochain technology for advanced medicines. The company is based in Histon, UK. Asymptote was founded in 1989. | Packaged Software | Director/Board Member | |
Biosafe SA
![]() Biosafe SA Medical/Nursing ServicesHealth Services Biosafe SA operates as a medical technology company. It provides automated adult stem cell processing services. The firm specializes in the field of adult stem cell therapy, serving stem cell banks, hospitals and research institutes. The company was founded by Claude Fell and Lia Fell-Zakrajsek in 1997 and is headquartered in Eysins, Switzerland. | Medical/Nursing Services | Chairman | |
GE Healthcare CTH Holding Ltd.
![]() GE Healthcare CTH Holding Ltd. Financial ConglomeratesFinance Founded in 2017, GE Healthcare CTH Holding Ltd. is an investment holding British company. Part of Danaher Corp., the company is based in Chalfont St. Giles, UK. | Financial Conglomerates | Director/Board Member |
Statistiche
Distribuzione geografica
Canada | 20 |
Stati Uniti | 14 |
Svezia | 12 |
Svizzera | 3 |
Regno Unito | 3 |
Settori
Health Technology | 11 |
Finance | 8 |
Commercial Services | 8 |
Consumer Services | 7 |
Health Services | 6 |
Posizioni
Director/Board Member | 51 |
Corporate Officer/Principal | 21 |
Chief Executive Officer | 11 |
Chief Tech/Sci/R&D Officer | 10 |
Chairman | 10 |
Contatti più connessi
Insiders | |
---|---|
Michael Nobrega | 22 |
Michael May | 14 |
Sofia Hjelmberg | 13 |
Sven Kili | 11 |
Christopher Paige | 10 |
Peter Zandstra | 10 |
Reni J. Benjamin | 9 |
Kim Warren | 8 |
Jonathan Yeh | 8 |
Claudia Zylberberg | 6 |
Karin Flyborg | 5 |
Joan Sheehan | 3 |
Philip Vanek | 2 |
Donna Wall | 1 |
Leah Cowen | 1 |
- Borsa valori
- Insiders
- Jana Machan
- Connessioni Società